Publication

Insomnia symptoms and biomarkers of monocyte activation, systemic inflammation, and coagulation in HIV: Veterans Aging Cohort Study

Downloadable Content

Persistent URL
Last modified
  • 05/20/2025
Type of Material
Authors
    Brittanny M. Polanka, Johns Hopkins UniversitySuman Kundu, Vanderbilt UniversityKaku A. So-Armah, Boston UniversityMatthew S. Freiberg, Vanderbilt UniversitySamir K. Gupta, Indiana UniversityTamika C. B. Zapolski, Indiana UniversityAdam T. Hirsh, Indiana UniversityRoger J. Bedimo, VA North Texas Healthcare SystemMatthew J. Budoff, Lundquist InstituteAdeel A. Butt, VA Pittsburgh Healthcare SystemChung-Chou. H. Chang, University of PittsburghStephen S. Gottlieb, University of MarylandVincent Marconi, Emory UniversityJulie A. Womack, VA Connecticut Healthcare SystemJesse C. Stewart, Indiana University
Language
  • English
Date
  • 2021-02-09
Publisher
  • Public Library of Science
Publication Version
Copyright Statement
  • This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 16
Issue
  • 2
Start Page
  • e0246073
End Page
  • e0246073
Grant/Funding Information
  • This analysis was funded by grant R01HL126557 from the National Heart, Lung, and Blood Institute/National Institutes of Health awarded to MF, SG, and JS.
  • The Veterans Aging Cohort Study was funded by grant U10AA13566 from the National Institute on Alcohol Abuse and Alcoholism and Veterans Health Administration Public Health Strategic Health Core Group.
Supplemental Material (URL)
Abstract
  • Background Insomnia may be a risk factor for cardiovascular disease in HIV (HIV-CVD); however, mechanisms have yet to be elucidated. Methods We examined cross-sectional associations of insomnia symptoms with biological mechanisms of HIV-CVD (immune activation, systemic inflammation, and coagulation) among 1,542 people with HIV from the Veterans Aging Cohort Study (VACS) Biomarker Cohort. Past-month insomnia symptoms were assessed by the item, “Difficulty falling or staying asleep?,” with the following response options: “I do not have this symptom” or “I have this symptom and…” “it doesn’t bother me,” “it bothers me a little,” “it bothers me,” “it bothers me a lot.” Circulating levels of the monocyte activation marker soluble CD14 (sCD14), inflammatory marker interleukin-6 (IL-6), and coagulation marker D-dimer were determined from blood specimens. Demographic- and fully-adjusted (CVD risk factors, potential confounders, HIV-related factors) regression models were constructed, with log-transformed biomarker variables as the outcomes. We present the exponentiated regression coefficient (exp[b]) and its 95% confidence interval (CI). Results We observed no significant associations between insomnia symptoms and sCD14 or IL-6. For D-dimer, veterans in the “Bothers a Lot” group had, on average, 17% higher D-dimer than veterans in the “No Difficulty Falling or Staying Asleep” group in the demographic-adjusted model (exp[b] = 1.17, 95%CI = 1.01–1.37, p = .04). This association was nonsignificant in the fully-adjusted model (exp[b] = 1.09, 95%CI = 0.94–1.26, p = .27). Conclusion We observed little evidence of relationships between insomnia symptoms and markers of biological mechanisms of HIV-CVD. Other mechanisms may be responsible for the insomnia-CVD relationship in HIV; however, future studies with comprehensive assessments of insomnia symptoms are warranted.
Author Notes
Keywords
Research Categories
  • Health Sciences, Immunology
  • Health Sciences, Medicine and Surgery
  • Health Sciences, Health Care Management

Tools

Relations

In Collection:

Items